
Celltrove is a clinical research technology company that accelerates drug development by providing AI-powered, integrated digital workflows and global talent to streamline and optimize clinical trials. Their platform offers end-to-end biometrics, advisory services, imaging solutions, and patient access/site solutions to reduce costs, improve trial success rates, and simplify operations for biopharma companies, CROs, clinical technology providers, and clinical site investigators. With over 25 years of experience and expertise across 3,600 clinical studies, Celltrove leverages machine learning analytics to improve predictive accuracy of clinical success by up to 89%, enabling faster, more efficient, and patient-centric clinical trials worldwide. The company is led by founder Bhavesh Acharya and operates globally with a focus on bridging Western and Asian drug development ecosystems.

Celltrove is a clinical research technology company that accelerates drug development by providing AI-powered, integrated digital workflows and global talent to streamline and optimize clinical trials. Their platform offers end-to-end biometrics, advisory services, imaging solutions, and patient access/site solutions to reduce costs, improve trial success rates, and simplify operations for biopharma companies, CROs, clinical technology providers, and clinical site investigators. With over 25 years of experience and expertise across 3,600 clinical studies, Celltrove leverages machine learning analytics to improve predictive accuracy of clinical success by up to 89%, enabling faster, more efficient, and patient-centric clinical trials worldwide. The company is led by founder Bhavesh Acharya and operates globally with a focus on bridging Western and Asian drug development ecosystems.